N. Bara

Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial

Laura Ciaffi, Sinata Koulla‐Shiro, Adrien Sawadogo et al. · The Lancet HIV · 2017 · 71 citations

Lamivudine Dual Therapy, Superiority Trial, Protease Inhibitor +9

The Global Registry for Hereditary Angioedema due to C1-Inhibitor Deficiency

Andrea Zanichelli, Henriette Farkas, L. Bouillet et al. · Clinical Reviews in Allergy & Immunology · 2021 · 22 citations · Full text

Hypertension, Vascular Disease, Immunology +28

Global perceptions of the current and future impacts of COVID-19 on hereditary angioedema management

Vesna Grivcheva‐Panovska, Timothy Craig, Hilary Longhurst et al. · Allergy and Asthma Proceedings · 2022 · 16 citations · Full text

Recurrent ascites: a need to evaluate for hereditary angio-oedema

Gabriella Gábos, Daniela Dobru, Enikő Mihály et al. · The Lancet · 2017 · 14 citations

Vascular Disease, Cardiovascular Disease, Vascular Malformation +8

Consequences of Misdiagnosed and Mismanaged Hereditary Angioedema Laryngeal Attacks: An Overview of Cases from the Romanian Registry

Dumitru Moldovan, N. Bara, Valentin Nădășan et al. · Case Reports in Emergency Medicine · 2018 · 14 citations · Full text

Romanian Registry, Hereditary Angioedema, Patient Safety +6